What is GeneDx Holdings's price / sales?

GeneDx Holdings (WGS) reported price / sales of 4.2× in Q1 2026.

How has GeneDx Holdings's price / sales changed year-over-year?

GeneDx Holdings's price / sales decreased by 43.6% year-over-year, from 7.5× to 4.2×.

What is the long-term trend for GeneDx Holdings's price / sales?

Over 4 years (2021 to 2025), GeneDx Holdings's price / sales has grown at a -52.1% compound annual growth rate (CAGR), from 167.5× to 8.8×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

GeneDx Holdings WGS Price / sales

Price / sales at other companies

Natera, Inc.NTRA

11.3×+0.9×

Tempus AI, Inc.TEM

5.9×-4.4×

Bio-Rad LaboratoriesBIO

2.9×+0.2×

Quest DiagnosticsDGX

1.9×+0.1×

RevvityRVTY

3.4×-1.2×

Labcorp HoldingsLH

1.6×+0.1×

Other financials

Income statement

See full

Revenue$102.3M+17.4%

Gross profit$68.2M+16.6%

Operating income-$57.5M-1,163%

Net income-$63.3M-870%

EPS (diluted)-$2.16-839%

Balance sheet

See full

Cash & equivalents$94.9M-5.7%

Total debt$96.7M+82.5%

Total equity$254.1M-1.3%

Total assets$506.3M+13.4%

Cash flow

See full

Operating cash flow-$32.4M-418%

CapEx$6.5M+5.3%

Free cash flow-$38.9M-1,059%

Valuation

See full

Market cap$1.72B-24.3%

Enterprise value$1.73B-22.8%

Profitability

See full

Gross margin69.6%+4.3pp

Operating margin-14.9%—

Net margin-17.6%—

FCF margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-30.4%—

Debt / equity0.4×+0.2×

Current ratio3.1×-0.2×

Where this comes from

Calculated from GeneDx Holdings’s reported figures.

market cap/total revenue=4.2×

Based on the most recent quarter.

The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about GeneDx Holdings's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GeneDx Holdings's price / sales?: GeneDx Holdings (WGS) reported price / sales of 4.2× in Q1 2026.
How has GeneDx Holdings's price / sales changed year-over-year?: GeneDx Holdings's price / sales decreased by 43.6% year-over-year, from 7.5× to 4.2×.
What is the long-term trend for GeneDx Holdings's price / sales?: Over 4 years (2021 to 2025), GeneDx Holdings's price / sales has grown at a -52.1% compound annual growth rate (CAGR), from 167.5× to 8.8×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.